Tofacitinib in patients with ankylosing spondylitis: a phase II, 16-week, randomised, placebo-controlled, dose-ranging study

Author(s):
Heijde, D. van der; Deodhar, A.; Wei, J.C.; Drescher, E.; Fleishaker, D.; Hendrikx, T.; Li, D.; Menon, S.; Kanik, K.S.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-08-31
Language
English
Is part of
Annals of the Rheumatic Diseases (2017), Vol. 76, no. 8, p. 1340-1347
hdl
1887/114622
doi
10.1136/annrheumdis-2016-210322